Approval · Notice of Compliance 7195 · 2005
LUVERIS: Notice of Compliance 7195
Issued June 24, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7195
- Date
- June 24, 2005
- Company
- Serono Canada Inc.
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Gonadotrophin
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LUVERIS | 02269066 | Marketed |
Medicinal ingredients
- LUTROPIN ALFA 75 UNIT per VIAL